With an ageing population there is a move towards the use of assisted living technologies (ALTs) to 14 provide social care and health care services, and to improve service processes. These technologies 15 are at the forefront of the integration of health and social care. However, economic evaluations of 16 ALTs, and indeed economic evaluations of any interventions providing both health benefits and 17 benefits beyond health are complex. This paper considers the challenges faced by evaluators and 18 presents a method of economic evaluation for use with interventions where traditional methods 19 may not be suitable for informing funders and decision makers. We propose a method, combining 20 economic evaluation techniques, that can accommodate health outcomes and outcomes beyond 21 health through the use of a common numeraire. Such economic evaluations can benefit both the 22 public and private sector, firstly by ensuring the efficient allocation of resources. And secondly, by 23 providing information for individuals who, in the market for ALTs, face consumption decisions that 24 are infrequent and for which there may be no other sources of information. We consider these 25 issues in the welfarist, extra-welfarist and capabilities framework, which we link to attributes in an 26 individual production model. This approach allows for the valuation of the health component of any 27 such intervention and the valuation of key social care attributes and processes. Finally, we present a 28 2 set of considerations for evaluators highlighting the key issues that need to be considered in this 1 type of economic evaluation. 2
applies CBA, comparing the discounted future streams of incremental programme benefits with the 1 incremental programme costs to measure the net social benefits (Drummond et al., 2005) . 2 CBA considers issues of allocative efficiency across and within sectors and may be suitable when the 3 outcomes are varied and process, such as the method of delivery (eg whether at home or at a 4 provider), may also be of value. However, CBA can be difficult to undertake as the values can be 5 confounded by ability-to-pay (Donaldson, 1999) , and in the case of social care and health care 6 interventions, confounded by potentially increasing expectations of the role of the state in their 7 provision (Ham et al., 2012) . Furthermore, in practical application, it seems that traditional CBA-8 based welfare economic analysis has not been widely accepted as the evaluative method of choice in 9 the health care setting. 10
CUA and 'extra-welfarism' 12
In rejecting the traditional welfarist approach to health care evaluation, the predominant evaluative 13 technique to emerge is the 'extra-welfarist' approach, which focuses on the benefits from 14 fundamental goods and their distribution and underpins most of the economic evaluations in health 15 (Culyer, 1989 , Hurley, 2014 . According to Coast et al. (2008b) extra-welfarism grew from the work 16 of Sen (1980, 2002) focusing on functionings and capability -the ability of individuals to function. 17 Sen has suggested functionings such as 'moving' or 'being in good health' and it is the focus on the 18 latter and the ability for an individual to be in good health that has led to the development of extra-19
welfarism. This notion of extra-welfarism is quite narrow (Coast et al., 2008b) and meant that in 20 economic evaluations of health interventions the fundamental good is health. This has led to a focus 21 on using quality adjusted life years (QALYs) as the main currency of outcome measurement (for an 22 excellent discussion of the welfarism, extra-welfarism and capabilities see Coast et al., 2008b) . This 23 approach, using QALYs in combination with the cost-utility analysis method, specifically does not 1 place value on benefits outside of health gains. 2 In order to capture benefits beyond health an alternative approach to the method we are suggesting 3 would be to move away from a health focused version of 'extra-welfarism' and develop a broader 4 utility measure to use in CUA, such as the 'capability-QALY' proposed by Cookson (2005) , the 'super-5 QALY' as described by Buxton (2008) , or the WELBY (wellbeing adjusted life years) (Brazier and 6 Tsuchiya, 2015). A super-QALY measure would require knowledge of what people value that might 7 be affected by the intervention and a means to capture those effects. Similar problems would be 8 raised by the use of the WELBY, which would also risk removing much of the focus from health. 9 10
The challenges of conducting economic evaluations on ALTs 11
ALTs present many challenges for the traditional economic evaluation approaches. These challenges 12 may explain why cost-effectiveness studies have struggled to make the case for ALTs in the past. 13
The outcomes of ALTs 14
Using CUA methods with QALYs is the core economic evaluation tool used to investigate value for 15 money in health care. However, focusing on health benefits from the 'extra-welfarist' position is 16 challenged by the possibility of multiple outcomes (Birch and Donaldson, 2003) . For ALTs there are 17 outcomes that may be important for health, for social care and for process -improving health and 18 social care may partly revolve around service delivery rather than solely on outcomes. The focus on 19 health and QALYs seems inappropriate in this context and broader measures of outcomes are 20 required. Sen's (1980) notion of capabilities, which is already gaining ground in the area of health 21 (Coast et al., 2008a , Coast et al, 2008c , could provide a way forward. 22
As social care can be a mechanism to support people to improve their opportunities and life 1 chances, the capabilities approach may offer an insight into how the benefits of social care 2 technologies might be identified and quantified. However, the individual nature of capabilities 3 raises difficulties when it comes to technologies not purchased by individuals. Nussbaum 4 attempted to identify ten key capabilities that should be supported by all democracies, some of 5 which could be affected by social care (Nussbaum, 2011). The general nature of Nussbaum's 6 capabilities, for example: "Life. Being able to live to the end of a human life of normal length; not 7 dying prematurely, or before one's life is so reduced as to be not worth living."; are neither easy to 8 establish small marginal effect on nor easily valued. If capabilities were identified that were specific 9 enough to social care interventions, when those freedoms are financially constrained, it is unclear 10 what would be valued in any evaluation: the freedom itself or compensation for the inability or 11 inopportunity to be availed of the freedom. Also, unlike health related utility that, when combined 12 with mortality, produces QALYs for which there is a societal value associated, as yet there is no 13
evidence to understand what society might deem appropriate to pay for any increase in capability. 14 In particular, the notion of 'capability maximisation' as an objective has recently been challenged in 15 favour of focusing on the concept of 'sufficient' (Mitchell et al, 2015) . 16 Two potential ways forward would be, firstly, to expand the utility basis of QALYs to take account of 17 capabilities (and process). However, this would require knowledge of which elements of utility were 18 included in any measure (similar arguments have been raised regarding the use of bolt-ons to the 19 EQ-5D, see Brazier and Tsuchiya (2015)). Even if the utility elements could be identified and a utility 20 score developed, individuals would be valuing an overall utility score (in the same way that 21 willingness-to-pay (WTP) of overall programmes provides a single monetary valuation of the 22 benefits). This would provide no information on how the individual elements that comprised the 23 score were valued. It would also require the development of a new threshold level to determine cost 24 effectiveness.
A second approach would be to use an instrument. One instrument designed to estimate the effect 1 of interventions targeting older people is ICECAP-O (Grewal et al., 2006) , where Attachment (love 2 and friendship), Security (thinking about the future without concern), Role (doing things that make 3 you feel valued), Enjoyment (enjoyment and pleasure) and Control (independence) are the 4 functions. 5
Given the diverse nature of social care interventions, a generic instrument would not necessarily be 6 appropriate for any given technology. Furthermore, given the diversity of social care it may be that 7 even condition specific instruments would not be sensitive enough to be of benefit to evaluators. 8
What is required is a way of conceptualising attributes (that might include capabilities) so they can 9 be valued and combined with health benefits. We suggest that it is possible to link capabilities to 10 attributes through a household production framework based on the work of Lancaster (1966) . 11
ALTs and attributes 12
In Lancaster's model, individuals use inputs to produce fundamental outputs or more broadly utility. 13 For example, individuals purchase goods and services that provide health attributes and, through a 14 consumption technology, use these inputs to produce health. It is possible to think of capabilities as 15 outputs from this production process, in which case individuals will consume goods and services that 16 provide attributes that can used to produce capabilities. For example, a key capability may be 'bodily 17 integrity' and individuals would consume goods and services that would provide the attribute 'bodily 18 integrity'. Lancaster's theoretical model allows us to align the attributes of goods with capabilities. 19
If we think of goods as sets of attributes it is possible to see how evaluating ALTs becomes 20 problematic. If we are considering interventions that provide a range of outcomes, and where 21 process may be of value, then it is possible that individuals are willing to trade-off these different 22 attributes against each other. Health care contains attributes of social care and social care contains 23 attributes of health care. They can be substituted for one another, whereas social care attributes 24 may enhance health care attributes meaning that they are also complements (Wildman and 1
McMeekin, 2014). 2
Individuals do not value the services 'health care' or 'social care' care but the attributes that 3 comprise 'health care' and 'social care'. For example, the process through which the health care or 4 the social care is provided is a valued attribute. In this case it is useful to be able to value attributes 5 individually. It is also possible that these attributes may be valued differently; for example, process 6 attributes may be valued more highly than health attributes. In this scenario it would not be 7 possible, or would be complex, to use any measure that results in an overall score, such as the QALY, 8 a broader measure like the 'capability-QALY', the 'super-QALY', a WELBY or an instrument such as 9 the Social Care Related Quality of Life (Netten et al., 2012) that covers elements such as 'control over 10 daily life" or "Dignity". With any such approach, the way that domains are incorporated into an 11 overall metric and valued can be methodologically complex and problematic, and often overlooks 12 substitution effects or trade-offs that individuals are want to make. This problem is also true for CBA 13 approaches where the overall intervention is valued using a single WTP value -there is no way to 14 reveal the valuation of the individual attributes that make up the intervention on offer. 15
ALT Perspectives 16
One of the key decisions when undertaking economic evaluation is the perspective: which costs and 17 benefits should be accounted for in the analysis? While it is beyond the scope of this paper to 18 discuss all of the issues relating to perspectives, it is important to note some of the challenges that 19 economic evaluations of ALTs (and other interventions) face. Costs are often considered at the 20 service level but with interventions where costs may be met by different sectors such an approach 21 can be problematic. In many publicly provided health and social care systems the budgets are 22 separate and there is an incentive for the health care and the social care provider to try to shift costs 23 from their budgets. With health care and social care acting as substitutes it is possible that 24 individuals use health care services when they should use social care services. For example, if an ALTpromotes independence, perhaps by aiding mobility, this clearly provides a social care benefit. 1 However, the benefits that arise from cost savings may be largely felt in the health care sector, not 2 only in terms of reduced falls but also by shortening the length of stay in hospital by increasing 3 mobility. Regardless of these problems we believe that the service level is appropriate and below we 4 outline a cost sharing method based on where benefits accrue. 5 6 Benefits are usually considered from a social perspective and, in a CUA framework, focus on QALYs. 7
One advantage of the CBA/WTP approach is the ability to incorporate non-health benefits and other 8 potential externalities that may arise from any intervention (externalities may be incorporated by 9 individuals valuing them in their own WTP; for example if an intervention means that care can take 10 place at home then the externality of not requiring someone to take the individual to receive care 11 may be included in the WTP value). Such an approach means that individual valuation may partly 12 take account of preferences of others, such as carers or family members. 13
With dependent populations, and individuals who may struggle to make decisions in their best 14 interests, perhaps due to cognitive decline, there are many potential beneficiaries (Al Janabi et al, 15 2016). The treated individual may not be the sole beneficiary from the use of ALTs. Others including 16 public sector bodies, charities, immediate family and carers and more distant families, may also 17 benefit and may be making decisions on behalf of the treated. In the presence of many beneficiaries, 18 and moving away from health as the sole benefit to multi-dimensional benefits that include process, 19 it is valid to ask whose valuations of benefits should be included. 20
21
So whose values should count? And should all the identified attributes be included for valuation? It 22 has been suggested that the distinction between patient and public is a false one (Dolan, 1999) while 23 some, such as Gandjour (2010) It may be preferable that, like the EQ-5D which is based on population-based preferences, the values 7 assigned to attributes should reflect those of the wider population and not just those of the 8 individuals receiving care, their families and associated professionals. If ALTs are to be funded from 9 general taxation then it is right that their benefits should be valued by the wider population. If they 10 are paid for by individuals and their families who obtain benefits, the case for population based 11 valuations is weaker (Gold et al., 1996) . This is where the market has clear advantages over public 12 We have highlighted many challenges facing the economic evaluation of ALTs and in this section we 8 outline a new approach to evaluation that overcomes many of these challenges. Many of the 9 problems raised also occur in other areas of economic evaluation and our method could be widely 10 applied to economic evaluations where outcomes beyond health are valued. 11
Our method combines existing evaluation frameworks and a summary is presented in Figure 1 representations of net-benefits is well accepted (Stinnett and Mullahy, 1998) ). This may offer some 22 advantages to understanding the trade-offs between the attributes beyond health and health itself. 23
Perspective, comparator and attributes 3
Choosing the perspective and the attributes to be valued needs to be considered simultaneously 4 because the sets of attributes may vary according to perspective. The attributes of importance may 5 be different if we are considering an intervention from a decision makers' perspective compared to 6 an individual perspective, or family/carer perspective. 7
We suggest that important attributes could be determined by the decision maker or funder (it may 8 be the case that there are important attributes that are valued by the funder). An alternative 9 approach would be to undertake analysis that could identify a range of views and start to bring 10 together important attributes as identified by different populations. These could be populations of 11 decision makers, health and social care professionals, individuals using ALTs or family and carers. 12
One potentially useful method would be Q-methodology. This is a powerful mixed-methods 13 approach that can be used to elicit and group views using factor analysis. An example of applying 14 this method to the public's views on resource allocation can be found in Baker et al. (2014) . 15
Practically, it may not be possible to undertake such an analysis for each new intervention -16 economic evaluations are only one input into a decision making process and it is important that they 17 themselves are value for money. However, this practical difficulty applies to alternative approaches, 18 even the use of the 'super-QALY' would require considerable analysis to understand which elements 19 of utility should be included. Furthermore, as a new approach there are bound to be learning effects 20 and it may be the case that as more analysis is undertaken researchers iterate towards a set of 21 important attributes. 22
As in any economic evaluation, it is important to select the relevant comparator. If funding becomes 23 increasingly integrated then health evaluations, which use health measures or QALYs as theiroutcome, will need to be compared to evaluations of social care, where QALYs are unlikely to be the 1 most appropriate outcome. In order to obtain comparability between the valuations of benefits, 2 both elements will need to be measured on the same scale. We suggest that the best approach is to 3 measure both sets of benefits in terms of monetary valuations. However, the final decision on the 4 comparator lies with the researcher. 5
With perspective, the method we are proposing is flexible since the measurement of benefits from 6 health attributes and social care attributes are in the same currency -namely money. 7
Valuing social care attributes 8
Representative samples from the population should be used to value the attributes using WTP 9
methods. There are a number of reasons justifying this position. Firstly, while many countries 10 maintain a right to health care funded by the state and there are QALY thresholds in place, beyond 11 health care there are generally no such frameworks. This is true for any capabilities approach where 12 there is no clear agreement on what should comprise a list of capabilities. In this situation there is 13 neither an agreed threshold value, nor is there, unlike the QALY framework, a clear metric to apply a 14 threshold to. Secondly, obtaining valuations from the population would demonstrate wider WTP for 15 ALTs (or other technologies) that may eventually filter into the private market. Thirdly, the 16 valuations would allow for externalities to be accommodated and, at least in part, account for 17 benefits that accrue to other individuals -such as families or carers. Furthermore, these externalities 18 may stem from both the health care and the social care portion and so incorporate some of the 19 wider benefits arising from health care. 20
Contingent valuation (CV) approaches (a method of hypothetically valuing outcomes 'contingent' on 21 a market existing) or discrete choice experiment (DCE) methods could be applied. The DCE approach, 22 which elicits preferences across alternatives using a range of scenarios, seems particularly promising 23 since this would enable a first step towards understanding how attributes from social care could betraded-off against one another. In fact, if the health care elements are also included in this valuation 1 exercise then it would be possible to see how individuals made trade-offs between health care and 2 social care, or to investigate the complementarities. 
Combining health benefits 12
As stated above, our key development is measuring the health and social care benefits using the 13 same numeraire, in this case money. Our approach has three main elements: firstly, identify the 14 attributes that underpin the intervention, secondly, obtain monetary values for these attributes 15 using a DCE approach and thirdly, value the health benefit, in money, using either threshold (or 16 revealed decision making) approach, or using WTP based approaches. 17
Once researchers have valued social care and process attributes from an intervention then it is 18 important to combine these with health benefits. There are two ways to approach this problem. The 19 first is to use CBA to value the health portion of any intervention. The outcomes of the CBA would be 20 in monetary terms and could easily be combined with the valuations of the attributes from the DCE. 21
However, this approach would be moving away from the 'extra-welfarist' underpinnings of CUA. 22
A second avenue would be to use CUA. However, this presents a problem of how to combine 23 valuations in terms of QALYs with the monetary valuations of the attributes. There are twoapproaches that are available and the approach chosen will depend on whether the evaluator is a 1 searcher or surveyor of the value of a QALY . A searcher (researchers using 2 threshold values from decision making bodies) could apply the QALY threshold value as used by NICE 3 -conventionally accepted to be around £20,000 -£30,000 per QALY (McCabe et al., 2008) . The 4 surveyor (a more welfarist CBA approach) could use the WTP for a QALY based on values from 5 studies such as Donaldson et al. (2011) that obtained values of QALY ranging from £10,000 to 6 £70,000. 7
In the case where health is evaluated through CUA methods, the net monetary benefit of the health 8 element of any intervention could be derived by multiplying the number of QALYs with the 9 monetary value of a QALY, whether that is derived directly from a threshold value or from values 10 revealed from actual decision making (Claxton et al., 2015) to give health benefits measured in 11 monetary units. These values could then be combined with the attribute values, giving a 12 combination of the CBA and CUA approaches. Standard decision rules, such as ranking interventions 13 on the basis of benefit-cost ratios, could then be applied. 14 This technique also has the added advantage of addressing (some of) the issues in moving resources 15 between health and social care budgets. By measuring benefits in the same units it would be 16 possible to determine the proportion of benefits deriving from the health and social care outcomes. 17 In this case it would then be possible to apportion costs on the basis of similar proportions. So, for 18 example, if 60% of the benefits accrued from health then 60% of costs could then be attributed 19 towards health. 20
The combining of two principal existing economic evaluation techniques into one single framework 21 presents a novel approach to current methods as an immediate and practical solution for evaluating 22 health and social care interventions with outcomes that are necessarily going beyond health. By 23 continuing to capture the impact upon health in terms of a CUA, this is a natural evolution in 24 evaluation methods that enables wider outcomes to be captured and presented alongside healthoutcomes --and importantly, the use of CUA maintains the fundamental focus on health for the 1 health portion of the evaluation. inclusion of attributes as a key element of benefit valuation. This approach allows us to value 10 interventions that have social care benefits, process benefits and health benefits. It can also be 11 expanded to include social or business benefits depending on the perspective of the evaluation. 12
As a first step in the evaluation process, other attributes (beyond health) that are considered 13 relevant and important to the beneficiaries and/or decision-maker need to be identified; i.e. the 14 identification of attributes against which the impact of intervention should be evaluated. With any 15 new method, identifying key attributes will take time and, while an extensive list of attributes may 16 be identified, the attributes used do not necessarily have to be identical across interventions. We 17
propose that by eliciting views to estimate the value placed on wider gains produced by new social 18 care technologies, and combining this with standard health economic methods, a more robust 19 approach could be applied to evaluate interventions reflective of a more integrated health system. 20 This is innovative as it combines current methods associated with both technical and allocative 21 efficiency and would assist decision-makers to allocate resources more efficiently across health and 22 social care budgets. Furthermore, by providing valuations of the benefits of ALTs, evaluations will 23 also provide information for the private market, giving consumers more information regarding the 1 efficacy of ALTs. 2 However, there are key methodological challenges that still need to be overcome. Firstly, it would be 3 helpful if there were an already agreed set of attributes. It may not be feasible to derive the 4 attributes and evaluate them with each intervention and each evaluation. If an appropriate set of 5 attributes and their values could be derived then these could be applied to each evaluation. 6
A second challenge regards the perspective of studies. Where the benefits (and costs) of social care 7
interventions accrue is a difficult matter for evaluators to decide. Such issues are complicated 8 further because social care is often aimed at vulnerable individuals where decision making may be 9 impaired, and where externalities of care -eg the benefits of safety in the home and independence -10 may be felt by health systems and society as a whole. Furthermore, if there is an increasing drive for 11 the development of a thriving private market in ALTs, then how much should the business 12 perspective also be included in the evaluation? These issues mean that the selected attributes may 13 be different depending on the perspective taken. 14 A third challenge, stemming from the point above, is how to resolve the valuations placed on 15 attributes when the stakeholders involved have different preferences across attributes. We currently 16 suggest using representative samples from the population to value attributes; however it is possible 17 that the methods could be develop further to try and account for the many different views held in 18 value society places on a QALY can vary from £10,000 to £70,000 depending of the severity of the 9 condition that the treatment addresses. Whether health and social care should be valued by setting 10 a threshold to maximise output from an exogenously-set health budget or whether it should reflect 11 the value the public put on health and social care, is a broader debate that is beyond the current 12 scope of this paper. 13 The sixth challenge is the decision making process. What would the decision rule be for the 14 interventions evaluated, and who would be the decision maker? Would this role stay within the 15 remit of NICE or should the decision maker include wider representatives from social care? We 16 suggest that the current approach to decision making is maintained. Economic evaluations are an 17 input into the decision making process and our method allows decision makers to be more informed. 18
It is not a decision tool in its own right. This view is largely pragmatic, since NICE has the experience 19 as such a decision maker and a wider discussion of how to integrate health and social care decision 20 making is required. 21
A final challenge concerns aligning the equity elements to the method outlined above. Much of the 22 capabilities literature has focussed on equity and challenges utility based maximisation frameworks 23 (Coast et al. 2008c , Mitchell et al., 2015 . Equity issues could be incorporated through the valuationThere are many challenges still to be addressed but we believe that we have started to clarify 1 economic evaluations of ALTs. Many of our arguments echo those expounded in Coast et al. (2008a) 2 although our application is broader than health interventions and covers interventions that are at 3 the forefront of integrating health and social care. 4
In conclusion we raise considerations for researchers conducting economics evaluations outcomes 5 are complex and processes are also potentially of value. 6
1. What is the perspective of the economic evaluation? Who are the main beneficiaries -7 patients/consumers, carers, health and social care systems, businesses, etc? 8 2. Select the attributes of the intervention using Q-methodology. We hope that further research can 9 identify key attributes; however, it may be that for each economic evaluation attributes can be 10 identified by researchers or funders, or that qualitative methods can be used of obtain key attributes 11 from individuals and family members. 
